ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

Hatfield Asks AACR to Join In forming “Triangle Coalition”

June 23, 1989

Tobacco Use Research Centers Funded

October 22, 1999

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

NIH Emerges From Republican Revolution With Another Increase in Appropriations

October 4, 1996

55 NCI Grantees Win Shannon Awards, NCI gets $5.2 Mil.

October 4, 1991